Evidence map›Paper›PMID 29576218›Full record

ArticleAmerican journal of human genetics2018

Mutations in PMPCB Encoding the Catalytic Subunit of the Mitochondrial Presequence Protease Cause Neurodegeneration in Early Childhood.

F-Nora Vögtle, Björn Brändl, Austin Larson, Manuela Pendziwiat, Marisa W Friederich, Susan M White, Alice Basinger, Cansu Kücükköse, Hiltrud Muhle, Johanna A Jähn and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Modelling mitochondrial diseases in neuronsJournal of neuromuscular diseases · 2025
    Pooled it
  2. Platelet-derived microparticles induce CD8Experimental & molecular medicine · 2026
    Article
  3. HUNTER catches N-terminal prey of ICP55 in the mitochondria.Nature structural & molecular biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Proteolytic control of mitochondrial protein translocases.Protein science : a publication of the Protein Society · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. A Multi-Dimensional Approach to Map Disease Relationships Challenges Classical Disease Views.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. A tale of two pathways: Regulation of proteostasis by UPRCurrent opinion in neurobiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 13 institutions in 4 countries.

F-Nora VögtleInstitute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg 79104, Germany. Electronic address: nora.voegtle@biochemie.uni-freiburg.de.
Björn BrändlDepartment of Psychiatry and Psychotherapy, University Hospital Schleswig Holstein, Kiel 24105, Germany.
Austin LarsonDepartment of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado, Aurora, CO 80045, USA.
Manuela PendziwiatDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.
Marisa W FriederichDepartment of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado, Aurora, CO 80045, USA.
Susan M WhiteVictorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia.
Alice BasingerCook Children's Physician Network, Department of Genetics, Fort Worth, TX 76102, USA.
Cansu KücükköseInstitute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg 79104, Germany; Faculty of Biology, University of Freiburg, Freiburg 79104, Germany.
Hiltrud MuhleDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.
Johanna A JähnDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.
Oliver KeminerFraunhofer-Institut für Molekularbiologie und Angewandte Ökologie IME, ScreeningPort, Hamburg 22525, Germany.
Katherine L HelbigDivision of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Carolyn F DeltoRudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg 97080, Germany.
Lisa MyketinInstitute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg 79104, Germany.
Dirk MossmannInstitute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg 79104, Germany.
Nils BurgerInstitute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg 79104, Germany.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Audrey BurnettCook Children's Physician Network, Department of Genetics, Fort Worth, TX 76102, USA.
Andreas van BaalenDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.
Mark A LovellDepartment of Pathology, University of Colorado, Aurora, CO 80045, USA.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Maie WalshAdult Genetic Medicine, Royal Melbourne Hospital, Melbourne, VIC 3052, Australia.
Hung-Chun YuDepartment of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado, Aurora, CO 80045, USA.
Deepali N ShindeDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA 92656, USA.
Ulrich StephaniDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.
Johan L K Van HoveDepartment of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado, Aurora, CO 80045, USA.
Franz-Josef MüllerDepartment of Psychiatry and Psychotherapy, University Hospital Schleswig Holstein, Kiel 24105, Germany; Max Planck Institute for Molecular Genetics, Berlin 14195, Germany.
Ingo HelbigDepartment of Neuropediatrics, Christian-Albrechts-University of Kiel, Kiel 24105, Germany; Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Electronic address: helbigi@email.chop.edu.
Kiel University · DEUniversity of Freiburg · DEUniversity of Colorado Anschutz Medical Campus · USChildren's Hospital of Philadelphia · USCook Children's Health Care System · USUniversity Hospital Schleswig-Holstein · DEUniversity of Colorado Denver · USYokohama City University · JPAmbry Genetics (United States) · USFraunhofer Institute for Molecular Biology and Applied Ecology · DEThe Royal Melbourne Hospital · AUUniversity of Würzburg · DEVictorian Clinical Genetics Services · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial disorders causing neurodegeneration in childhood are genetically heterogeneous, and the underlying genetic etiology remains unknown in many affected individuals. We identified biallelic variants in PMPCB in individuals of four families including one family with two affected siblings with neurodegeneration and cerebellar atrophy. PMPCB encodes the catalytic subunit of the essential mitochondrial processing protease (MPP), which is required for maturation of the majority of mitochondrial precursor proteins. Mitochondria isolated from two fibroblast cell lines and induced pluripotent stem cells derived from one affected individual and differentiated neuroepithelial stem cells showed reduced PMPCB levels and accumulation of the processing intermediate of frataxin, a sensitive substrate for MPP dysfunction. Introduction of the identified PMPCB variants into the homologous S. cerevisiae Mas1 protein resulted in a severe growth and MPP processing defect leading to the accumulation of mitochondrial precursor proteins and early impairment of the biogenesis of iron-sulfur clusters, which are indispensable for a broad range of crucial cellular functions. Analysis of biopsy materials of an affected individual revealed changes and decreased activity in iron-sulfur cluster-containing respiratory chain complexes and dysfunction of mitochondrial and cytosolic Fe-S cluster-dependent enzymes. We conclude that biallelic mutations in PMPCB cause defects in MPP proteolytic activity leading to dysregulation of iron-sulfur cluster biogenesis and triggering a complex neurological phenotype of neurodegeneration in early childhood.

Indexed as

Catalytic DomainChildChild, PreschoolDermisElectron TransportFemaleFibroblastsHumansInduced Pluripotent Stem CellsIron-Sulfur ProteinsMagnetic Resonance ImagingMaleMetalloendopeptidasesMitochondriaMitochondrial Processing PeptidaseMutationIron-Sulfur ProteinsMAS1 protein, humanMetalloendopeptidasesMitochondrial Processing PeptidaseProto-Oncogene MasSaccharomyces cerevisiae Proteinsmitochondrial diseasemitochondrial presequence proteasemitochondrial protein biogenesismitochondrial targeting signalneurodegeneration

Identifiers

PMID29576218
PMCPMC5985287
OpenAlexW2790883924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.